BioVie closes ~$21M public offering of stock and warrants

BIOVIE INC.

Issued 15M shares, pre-funded warrants for 6M shares, and common warrants for 10.5M shares at $1.00 combined price.
Gross proceeds ~$21M; net after placement agent fees and expenses of ~$2.2M.
Common warrants exercisable at $1.50 per share for five years from issuance.
Acuitas warrant exercise price adjusted from $1.82 to $1.00 per the offering price.
Company intends net proceeds for working capital and general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.